Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Egg powder for MAM and EED in children
NCT06002438Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Percent lactulose excretion at 24 weeks and Change in length-for-age z-score at 24 weeks. Started Oct 2023; status: completed.
Beyond the preview
Go deeper on NCT06002438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06002438.